Conference Coverage

Nicotinamide cuts rate of nonmelanoma skin cancer in those at high risk

Publish date: May 14, 2015

 

FROM THE ASCO 2015 PRESSCAST

References

Dr. Damian disclosed no relevant conflicts of interest. The study was funded by the National Health & Medical Research Council.

Pages

Recommended Reading

Drink more coffee to prevent a second BCC
MDedge Internal Medicine
Treat actinic keratoses initially with field therapy and follow with lesional therapy
MDedge Internal Medicine
Skin cancer treatment costs skyrocket over past decade
MDedge Internal Medicine
Low-risk actinic keratosis? No such thing
MDedge Internal Medicine
Burns, fainting, eyes most common indoor tanning injuries
MDedge Internal Medicine
MEK inhibitors can induce skin eruptions with distinctive duskiness
MDedge Internal Medicine
Melanoma incidence highest in Oregon, lowest in Texas in 2015
MDedge Internal Medicine
VIDEO: PDT tops blue-light therapy for actinic keratosis
MDedge Internal Medicine
Avoid voriconazole in transplant patients at risk for skin cancer
MDedge Internal Medicine
Teens who tan indoors do it often
MDedge Internal Medicine